MD 64.60 Mednax Inc $MD Hit a 52 week high of 64.6
Post# of 49
MD Recent Posts: http://investorshangout.com/Mednax-Inc-MD-51757/
MD Mednax Inc Recent Headline News
Watch for Mednax to Potentially Pullback After Gaining 2.52% Yesterday
Comtex SmarTrend(R) - Mon Nov 17, 5:52PM CST
Mednax (NYSE:MD) traded in a range yesterday that spanned from a low of $62.63 to a high of $64.90. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $62.87 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MD: 64.47 (+0.09)
Post Earnings Update: Mednax Has Climbed 2.1% Higher in Past 2 Weeks (MD)
Comtex SmarTrend(R) - Mon Nov 17, 4:24PM CST
18 days ago, on October 30th, 2014, Mednax (NYSE:MD) reported its earnings. Analysts, on average, expected earnings of $0.85 per share on sales of $619.3 million. The company actually reported EPS of $0.86 on sales of $626.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $7.2 million. Since the company's report, shares of Mednax have risen from $61.50 to $62.80, representing a gain of 2.1% in the past 18 days.
MD: 64.47 (+0.09)
Shares of MD Up 13.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 12, 9:28AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 3 weeks, Mednax has returned 13.83% as of today's recent price of $61.89.
MD: 64.47 (+0.09)
MEDNAX to Present at the Stifel 2014 Healthcare Conference
Business Wire - Wed Nov 12, 6:00AM CST
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Tuesday, November 18, 2014 at 11:30 a.m. EST to investors attending the Stifel 2014 Healthcare Conference in New York.
MD: 64.47 (+0.09)
Earnings Flashback: Since Reporting Quarterly Results 1 Week Ago Mednax Is Up 1.1% (MD)
Comtex SmarTrend(R) - Mon Nov 10, 1:47PM CST
When Mednax (NYSE:MD) reported earnings 11 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $0.85 on sales of $619.3 million. Mednax actually reported earnings of $0.86 per share on sales of $626.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $7.2 million. Since the company's report, shares of Mednax have risen from $61.50 to $62.18, representing a gain of 1.1% in the past 11 days.
MD: 64.47 (+0.09)
MEDNAX to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire - Fri Nov 07, 6:00AM CST
MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Tuesday, November 11, 2014 at 4:30 p.m. MST to investors attending the 2014 Credit Suisse Healthcare Conference in Phoenix.
MD: 64.47 (+0.09)
Mednax: Improving Bargaining Position, But Some Risks Ahead
Investing Doc - Seeking Alpha - Wed Nov 05, 10:38AM CST
My previous investment thesis for Mednax (NYSE: MD ) remains intact after reviewing the company's third quarter results, and while shares are less attractive than they had been after last week's jump in price, I still view them as undervalued after...
MD: 64.47 (+0.09)
Mednax Shares Up 15.4% Since SmarTrend's Buy Recommendation (MD)
Comtex SmarTrend(R) - Wed Nov 05, 9:33AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 2 weeks, Mednax has returned 15.42% as of today's recent price of $62.76.
MD: 64.47 (+0.09)
MEDNAX's (MD) CEO Roger Medel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 1:30PM CDT
MD: 64.47 (+0.09)
NYSE stocks posting largest percentage increases
AP - Thu Oct 30, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
CALX: 10.83 (+0.15), NFX: 32.48 (-0.02), EGL: 43.09 (-0.17), V: 250.42 (+0.62), MPLX: 69.76 (+1.06), GNC: 42.96 (+0.07), VHI: 5.93 (-0.02), ROG: 72.12 (+0.95), ACCO: 9.01 (+0.04), CEB: 73.97 (+0.41), FLTX: 35.53 (+0.48), MD: 64.47 (+0.09)
Mednax (MD) Marked As A Barbarian At The Gate
at The Street - Thu Oct 30, 9:46AM CDT
Trade-Ideas LLC identified Mednax (MD) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MD: 64.47 (+0.09)
Mednax (MD) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:55AM CDT
MD: 64.47 (+0.09)
Mednax beats Street 3Q forecasts
Automated Insights - Thu Oct 30, 5:54AM CDT
SUNRISE, Fla. (AP) _ Mednax Inc. (MD) on Thursday reported earnings of $86.2 million in its third quarter.
MD: 64.47 (+0.09)
Mednax beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:18AM CDT
MD: 64.47 (+0.09)
MEDNAX Reports 2014 Third Quarter EPS of $0.86
Business Wire - Thu Oct 30, 5:01AM CDT
--Credit Facility Expanded to $1.5 Billion
MD: 64.47 (+0.09)
Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 70.60 (+0.04), ESRX: 79.42 (+0.36), DVA: 75.12 (-0.39), DGX: 63.28 (+0.24), MD: 64.47 (+0.09)
MEDNAX Announces Acquisition of Anesthesiology Practice in Georgia
Business Wire - Wed Oct 29, 6:00AM CDT
MEDNAX, Inc. (NYSE: MD) today announced the signing of a definitive agreement to acquire The NEXus Medical Group, LLC and its subsidiary, Meridian Anesthesia Consultants, LLC in Macon, Georgia.
MD: 64.46 (+0.08)
MedData Launches iPhone App to Improve Billing Reconciliation for Surgical Practices
Business Wire - Thu Oct 23, 8:02AM CDT
MedData, Inc., a leading national provider of "patient-focused" revenue cycle management and patient financial lifecycle services, announced the launch of Patient Lists, a new iPhone app designed to streamline the medical billing process for its surgical clients.
MD: 64.46 (+0.08)
Edgemont Capital Partners Completes Sale of Premier Physician Services to TeamHealth
Business Wire - Wed Oct 22, 5:01PM CDT
Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to Premier Physician Services, Inc. ("Premier" in the sale of the company to TeamHealth Holdings Inc. (NYSE:TMH). Terms of the transaction were not disclosed.
EVHC: 33.51 (+0.87), TMH: 55.48 (+0.65), MD: 64.46 (+0.08)
MEDNAX Announces Acquisition of Perinatology Practice in Texas
Business Wire - Mon Oct 20, 6:00AM CDT
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Houston Perinatal Associates, P.A., a private physician group practice based in Houston, Texas. The practice will become part of MEDNAX's Pediatrix Medical Group division.
MD: 64.46 (+0.08)